ArticleScientifica2026
Brown Yar Ko Rice Protects Against Hyperglycemia-Induced Endothelial Injury via Antioxidant and SIRT1 Activation.
Article in Scientifica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endothelial dysfunction and oxidative stress caused by hyperglycemia are the main contributors to vascular complications in patients with diabetes mellitus (DM), which is a significant global health issue. The downregulation of sirtuin 1 (SIRT1), a key regulator of antioxidant defenses, further exacerbates vascular damage in diabetic conditions. This study aimed to investigate the therapeutic effects of brown Yar Ko (YK) rice extract, a traditional variety from southern Thailand, on hyperglycemia-induced oxidative stress in human umbilical vein endothelial cells (HUVECs), with a focus on SIRT1 activation. Methodologically, YK rice was extracted and identified via triple quadrupole GC‒MS/MS. Antioxidant activity was assessed via DPPH and FRAP assays. A 30 mM glucose-stimulated HUVEC model was utilized to mimic diabetes in vitro. Oxidative stress, endothelial function, and DNA damage were evaluated via DCFH-DA, tubulogenesis, and γ-H2AX staining, respectively. SIRT1 expression was analyzed via western blotting, and downstream signaling pathways were predicted via pharmacological network analysis. The results of chemical profiling revealed that YK rice extract is rich in beneficial fatty acids (linoleic, oleic, and palmitic acids) and micronutrients. The extract presented a high total phenolic content and potent antioxidant activity, significantly reducing reactive oxygen species (ROS) levels and DNA damage in hyperglycemia-induced HUVECs. Functional assays demonstrated that YK rice extract improved angiogenic capacity and mitigated endothelial dysfunction under hyperglycemic conditions. Mechanistically, treatment with YK rice extract upregulated SIRT1 expression, as confirmed by immunofluorescence and western blot analyses. Network pharmacology revealed the SIRT1 with PPAR-α and PPAR-γ axis as a key pathway modulated by major YK rice constituents, potentially suggesting enhanced mitochondrial biogenesis and antioxidant gene expression. However, these proposed mechanisms require further experimental validation for definitive elucidation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.